New ITC Order 62: Denying Respondents' Motion for Summary Determination

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jb530

Rank: Mail Room [?]

Points: 48 [?]

Votes: 3 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

New ITC Order 62: Denying Respondents' Motion for Summary Determination

posted on May 31, 2013 05:04PM

Is this the second MSD that we were waiting for (I think it is)? If so, good news!!

15 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply